Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henri Huezo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chemistry & Biology|August 2, 2003
Microtiter cell-based assay for detection of agents that alter cellular levels of Her2 and EGFRHenri Huezo, Maria Vilenchik, Neal Rosen, et al.
Bioorganic & Medicinal Chemistry|September 6, 2002
Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinaseGabriela Chiosis, Brian Lucas, Alexander Shtil, et al.
Molecular Cancer Therapeutics|February 18, 2003
17AAG: low target binding affinity and potent cell activity--finding an explanationGabriela Chiosis, Henri Huezo, Neal Rosen, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Synthesis of novel fluorescent probes for the molecular chaperone Hsp90Laura Llauger-Bufi, Sara J Felts, Henri Huezo, et al.
Current Cancer Drug Targets|October 8, 2003
Development of purine-scaffold small molecule inhibitors of Hsp90Gabriela Chiosis, Brian Lucas, Henri Huezo, et al.
Journal of Biomolecular Screening|August 7, 2004
Development of a fluorescence polarization assay for the molecular chaperone Hsp90Joungnam Kim, Sara Felts, Laura Llauger, et al.
Chemistry & Biology|June 26, 2004
Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90Maria Vilenchik, David Solit, Andrea Basso, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemistry & Biology|August 2, 2003
Microtiter cell-based assay for detection of agents that alter cellular levels of Her2 and EGFRHenri Huezo, Maria Vilenchik, Neal Rosen, et al.
Bioorganic & Medicinal Chemistry|September 6, 2002
Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinaseGabriela Chiosis, Brian Lucas, Alexander Shtil, et al.
Molecular Cancer Therapeutics|February 18, 2003
17AAG: low target binding affinity and potent cell activity--finding an explanationGabriela Chiosis, Henri Huezo, Neal Rosen, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Synthesis of novel fluorescent probes for the molecular chaperone Hsp90Laura Llauger-Bufi, Sara J Felts, Henri Huezo, et al.
Current Cancer Drug Targets|October 8, 2003
Development of purine-scaffold small molecule inhibitors of Hsp90Gabriela Chiosis, Brian Lucas, Henri Huezo, et al.
Journal of Biomolecular Screening|August 7, 2004
Development of a fluorescence polarization assay for the molecular chaperone Hsp90Joungnam Kim, Sara Felts, Laura Llauger, et al.
Chemistry & Biology|June 26, 2004
Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90Maria Vilenchik, David Solit, Andrea Basso, et al.
Pageof 1